Juxtapid and Pravachol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Juxtapid (lomitapide mesylate) and Pravachol (pravastatin sodium). Common drug interactions include weight decreased among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Juxtapid and Pravachol. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Juxtapid?

Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.

What is Pravachol?

Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 24,382 Pravachol users. Check the latest studies of Pravachol.



On Jul, 17, 2026

18 people who take Juxtapid and Pravachol together, and have interactions are studied.

Juxtapid and Pravachol drug interactions.

What are the common drug interactions of Juxtapid and Pravachol, by gender? *:

female:

  1. Weight decreased
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Flushing (the warm, red condition of human skin)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Low density lipoprotein increased (cholesterol increased in blood)
  6. Blood pressure decreased
  7. Constipation
  8. Drug ineffective
  9. Hepatic enzyme increased
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Weight decreased
  2. Diarrhoea
  3. Myalgia (muscle pain)
  4. Nightmare (unpleasant dream)
  5. Poor quality sleep
  6. Somnambulism (sleep walking)
  7. Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)
  8. Therapeutic response unexpected
  9. Constipation
  10. Flatulence (flatus expelled through the anus)

What are the common drug interactions of Juxtapid and Pravachol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Constipation

40-49:

  1. Constipation
  2. Flatulence (flatus expelled through the anus)
  3. Weight decreased
  4. Weight increased
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Flushing (the warm, red condition of human skin)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Low density lipoprotein increased (cholesterol increased in blood)

50-59:

  1. Myalgia (muscle pain)
  2. Nightmare (unpleasant dream)
  3. Somnambulism (sleep walking)
  4. Weight decreased
  5. Hyperventilation

60+:

  1. Weight decreased
  2. Blood pressure decreased
  3. Diarrhoea
  4. Drug ineffective
  5. Hepatic enzyme increased
  6. Nausea (feeling of having an urge to vomit)
  7. Poor quality sleep
  8. Terminal insomnia (a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired)
  9. Therapeutic response unexpected

* Approximation only. Some reports may have incomplete information.

Do you take Juxtapid and Pravachol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Juxtapid and Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Juxtapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Juxtapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pravachol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lomitapide mesylate and pravastatin sodium (the active ingredients of Juxtapid and Pravachol, respectively), and Juxtapid and Pravachol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: